As of August 04, 2026, Iovance Biotherapeutics's top three insider holders are Wayne P. Rothbaum (Director, 28.07Mn shares), Frederick G Vogt (Interim Ceo General Counsel, 529.54K shares), Merrill A Mcpeak (Interim President And Ceo, 320.15K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Merrill A Mcpeak | Interim President And Ceo | 320,150 | 0 | 20 Feb, 2024 |
| Michael Weiser | - | 112,632 | 0 | 02 Jun, 2022 |
| Ryan D Maynard | - | 7,500 | 0 | 14 Nov, 2024 |
| Wayne P. Rothbaum | - | 0 | 28,067,333 | 20 Feb, 2024 |
| Igor Bilinsky | Chief Operating Officer | 125,766 | 0 | 06 Mar, 2026 |
| Iain D. Dukes | - | 54,000 | 0 | 20 Feb, 2024 |
| Frederick G Vogt | Interim Ceo General Counsel | 529,538 | 0 | 06 Mar, 2026 |
| Jean-Marc Bellemin | Chief Financial Officer | 60,529 | 0 | 04 Jun, 2025 |
| Finckenstein Friedrich Graf | Chief Medical Officer | 131,957 | 0 | 06 Mar, 2026 |
| Raj K. Puri | Chief Regulatory Officer | 239,230 | 0 | 06 Mar, 2026 |
| Daniel Gordon Kirby | Chief Commercial Officer | 139,381 | 0 | 26 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Raj K. Puri | Restricted Stock Units | A | 117,500 | $0.00 | 117,500 | D | A |
| 09 Mar, 2026 | Frederick G Vogt | Restricted Stock Units | A | 235,000 | $0.00 | 235,000 | D | A |
| 09 Mar, 2026 | Daniel Gordon Kirby | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 09 Mar, 2026 | Daniel Gordon Kirby | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 09 Mar, 2026 | Frederick G Vogt | Restricted Stock Units | A | 235,000 | $0.00 | 235,000 | D | A |
| 09 Mar, 2026 | Raj K. Puri | Restricted Stock Units | A | 117,500 | $0.00 | 117,500 | D | A |
| 09 Mar, 2026 | Finckenstein Friedrich Graf | Restricted Stock Units | A | 58,750 | $0.00 | 58,750 | D | A |
| 09 Mar, 2026 | Corleen M. Roche | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 09 Mar, 2026 | Frederick G Vogt | Restricted Stock Units | A | 235,000 | $0.00 | 235,000 | D | A |
| 09 Mar, 2026 | Igor Bilinsky | Restricted Stock Units | A | 117,500 | $0.00 | 117,500 | D | A |
| 09 Mar, 2026 | Corleen M. Roche | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 09 Mar, 2026 | Corleen M. Roche | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 09 Mar, 2026 | Raj K. Puri | Restricted Stock Units | A | 117,500 | $0.00 | 117,500 | D | A |
| 09 Mar, 2026 | Daniel Gordon Kirby | Restricted Stock Units | A | 132,200 | $0.00 | 132,200 | D | A |
| 05 Mar, 2026 | Raj K. Puri | Common Stock | A | 39,059 | $0.00 | 257,590 | D | M |
| 05 Mar, 2026 | Raj K. Puri | Common Stock | A | 39,059 | $0.00 | 257,590 | D | M |
| 05 Mar, 2026 | Raj K. Puri | Common Stock | A | 39,059 | $0.00 | 257,590 | D | M |
| 05 Mar, 2026 | Frederick G Vogt | Common Stock | A | 62,493 | $0.00 | 556,293 | D | M |
| 05 Mar, 2026 | Frederick G Vogt | Common Stock | A | 62,493 | $0.00 | 556,293 | D | M |
| 05 Mar, 2026 | Igor Bilinsky | Common Stock | A | 31,246 | $0.00 | 142,394 | D | M |